Drug discovery and mental illness
Barry D Lebowitz1, Herbert W Harris
1National Institute of Mental Health, Bethescla, Mel, USA.
Dialogues in Clinical Neuroscience
|October 29, 2011
Summary
Developing new mental disorder treatments requires a modern, mechanism-based approach. This involves integrating genetic and molecular medicine with updated clinical trial methods for better drug discovery.
Area of Science:
- Neuroscience and Psychiatry
- Pharmacology and Drug Discovery
- Genetics and Molecular Medicine
Background:
- Mental disorders represent a significant global health burden, causing substantial disability.
- Existing medications for mental disorders, while effective, have limitations due to incomplete understanding of disease mechanisms.
- The development of novel therapeutic strategies is hindered by a lack of deep pathophysiological insight.
Purpose of the Study:
- To advocate for a paradigm shift in mental disorder drug discovery towards mechanism-based approaches.
- To emphasize the integration of contemporary genetic and molecular tools in treatment development.
- To highlight the necessity of modernizing clinical trial methodologies to align with new discovery paradigms.
Main Methods:
- Leveraging advanced tools from genetic and molecular medicine for a deeper understanding of mental disorder pathophysiology.
- Implementing a mechanism-based drug discovery framework.
- Revising and modernizing established clinical trial designs and methodologies.
Main Results:
- The abstract does not present specific experimental results but outlines a proposed strategic direction for research.
- It identifies the need for a paradigm shift in drug discovery for mental health conditions.
- It emphasizes the synergy required between basic science advancements and clinical research practices.
Conclusions:
- A mechanism-based approach, powered by genetic and molecular medicine, is crucial for advancing mental disorder treatments.
- Modernizing clinical trial methodology is essential to effectively evaluate novel, mechanism-based therapies.
- Integrating these advancements promises to overcome current limitations and accelerate the development of more effective treatments for disabling mental disorders.
Related Concept Videos
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:27Diagnostic and Statistical Manual of Mental Disorders (DSM)
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
01:29Theoretical Approaches to Psychological Disorder
The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...